Shionogi, Inc.

News

04/26/2012	Shionogi files a New Drug Application for Ospemifene oral tablets 60 mg for the treatment of vulvar and vaginal atrophy
04/02/2012	Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV
01/25/2012	Study data show Cuvposa® reduced chronic severe drooling in patients ages 3-16 years-old with neurologic conditions
12/07/2011	Shionogi & Co., LTD. and Shionogi Inc. announce a favorable decision in Fortamet® preliminary injunction proceedings